




Searching News Database: insulin
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 10 Jun 2024
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
Abbott Receives U.S. FDA Clearance for Two New Over-the-Counter Continuous Glucose Monitoring Systems
HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
HSMN NewsFeed - 13 May 2022
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
HSMN NewsFeed - 28 Feb 2022
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
Medtronic Announces Launch of NuVent(TM) Eustachian Tube Dilation Balloon
HSMN NewsFeed - 2 Feb 2022
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
HSMN NewsFeed - 15 Nov 2021
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
HSMN NewsFeed - 21 Oct 2021
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
Austin L. Chiang, M.D., M.P.H. Joins Medtronic As Chief Medical Officer for Gastrointestinal Business
HSMN NewsFeed - 13 Sep 2021
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
ViaCyte Appoints Stem Cell Therapy Expert Dr. Timothy Kieffer as Chief Scientific Officer
HSMN NewsFeed - 26 May 2021
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
Medtronic Secures Two CE Mark Approvals for Guardian 4 Sensor & for InPen MDI Smart Insulin Pen
HSMN NewsFeed - 19 May 2021
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone
HSMN NewsFeed - 19 Mar 2021
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines
Oramed Forms a Joint Venture, Oravax Medical Inc., for the Development of Novel Oral COVID-19 Vaccines
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 24 Feb 2021
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
Truvian Sciences Raises More Than $105 Million in Oversubscribed Series C Financing
HSMN NewsFeed - 9 Feb 2021
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
Lannett Expands Strategic Relationship To Include Biosimilar Fast-Acting Insulin
HSMN NewsFeed - 19 Nov 2020
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes
HSMN NewsFeed - 1 Sep 2020
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
Abbott's FreeStyle(R) Libre 2 iCGM System Now Available to Medicare Beneficiaries
HSMN NewsFeed - 11 Jun 2020
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
Lannett Provides Update On Clinical Advancement Of Biosimilar Insulin Glargine, Following FDA Meeting
HSMN NewsFeed - 24 Apr 2020
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
Japan Grants Patent for Intralymphatic Administration of the Diabetes Vaccine Diamyd(R)
HSMN NewsFeed - 13 Mar 2020
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
EMD Serono and Pfizer Provide Update on Phase III JAVELIN Head and Neck 100 Study
HSMN NewsFeed - 3 Mar 2020
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
DxTerity Receives CE Mark for DxCollect(R) Fingerstick Blood RNA Stabilization Device
HSMN NewsFeed - 26 Feb 2020
Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial
Oramed Reports Positive Results in the Final Cohort of Its Phase 2b Oral Insulin Trial
HSMN NewsFeed - 28 Jan 2020
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
Lilly plans donation of 200,000 insulin KwikPens over next three years to support lower-income communities
HSMN NewsFeed - 16 Dec 2019
Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
HSMN NewsFeed - 24 Oct 2019
Provention Bio Announces PRV-031 (Teplizumab) Granted PRIME Designation by the European Medicines Agency
Provention Bio Announces PRV-031 (Teplizumab) Granted PRIME Designation by the European Medicines Agency
HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
HSMN NewsFeed - 13 Sep 2019
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
Abbott's Revolutionary FreeStyle(R) Libre System Now Reimbursed in the Two Largest Provinces in Canada
HSMN NewsFeed - 26 Jun 2019
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure
HSMN NewsFeed - 20 Mar 2019
Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company
Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company
HSMN NewsFeed - 6 Mar 2019
Instrumentation Laboratory Receives US FDA Clearance For New Gem Premier Chemstat(TM) Testing System
Instrumentation Laboratory Receives US FDA Clearance For New Gem Premier Chemstat(TM) Testing System
HSMN NewsFeed - 24 Jan 2019
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
BD Launches Ergonomic Pen Needle Technology to Help Optimize Injection Technique
HSMN NewsFeed - 14 Dec 2018
Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors
Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors
HSMN NewsFeed - 29 Nov 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
HSMN NewsFeed - 28 Nov 2018
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
Generex Biotechnology Expands Medical Device Portfolio With Acquisition of Olaregen Therapeutix Inc.
HSMN NewsFeed - 19 Oct 2018
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
Mylan and Biocon Announce Positive CHMP Opinion for Ogivri(R), Biosimilar Trastuzumab
HSMN NewsFeed - 4 Sep 2018
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
United Therapeutics And MannKind Announce Collaboration For Pulmonary Hypertension Products
HSMN NewsFeed - 9 Jul 2018
Companion Medical Announces FDA Clearance for the InPen System for Android
Companion Medical Announces FDA Clearance for the InPen System for Android
HSMN NewsFeed - 31 May 2018
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
Abbott Introduces the Afinion(TM) 2 Analyzer Rapid Test System for Diabetes Management
HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
HSMN NewsFeed - 8 Mar 2018
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
HSMN NewsFeed - 21 Feb 2018
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
HSMN NewsFeed - 7 Feb 2018
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
Abbott's App for FreeStyle(R) Libre System Now Available in Europe for Both iPhone and Android
HSMN NewsFeed - 10 Jan 2018
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
BYDUREON(R) BCise(TM) Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
HSMN NewsFeed - 14 Dec 2017
Companion Medical Announces U.S. Commercial Launch of Smart Insulin Pen System
Companion Medical Announces U.S. Commercial Launch of Smart Insulin Pen System
HSMN NewsFeed - 7 Dec 2017
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
Metacrine Completes Series B Financing to Advance Best-in-Class FXR Program into Clinical Development
HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
HSMN NewsFeed - 30 Nov 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
HSMN NewsFeed - 21 Sep 2017
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 21 Jul 2017
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma
HSMN NewsFeed - 19 May 2017
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
Sanofi Receives CHMP Recommendation for Approval of Insulin Lispro Biosimilar
HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
HSMN NewsFeed - 22 Mar 2017
AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors
AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors
HSMN NewsFeed - 27 Dec 2016
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene(R) Mist
Amphastar Pharmaceuticals Receives Complete Response Letter for Primatene(R) Mist
HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
HSMN NewsFeed - 28 Jul 2016
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
HSMN NewsFeed - 13 Jul 2016
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
HSMN NewsFeed - 8 Jun 2016
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
Orexigen Therapeutics Reports Favorable Markman Ruling in Contrave(R) Patent Litigation
HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
HSMN NewsFeed - 26 Jan 2016
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
Novo Nordisk Launches Tresiba(R) (insulin degludec injection 200 Units/mL) in the United States
HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
HSMN NewsFeed - 10 Dec 2015
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
HSMN NewsFeed - 4 Dec 2015
Samsung Bioepis' RENFLEXIS(R) Infliximab Biosimilar Receives Regulatory Approval in Korea
Samsung Bioepis' RENFLEXIS(R) Infliximab Biosimilar Receives Regulatory Approval in Korea
HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
HSMN NewsFeed - 30 Sep 2015
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
J. Robert Paulson and Jeffrey Mathiesen Appointed to Sun BioPharma Board of Directors
HSMN NewsFeed - 20 Jul 2015
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
BioMarin Provides Program Update for Talazoparib in Metastatic Breast Cancer
HSMN NewsFeed - 1 Jul 2015
GlySure Secures CE Mark and Launches Worldās First Continuous Intravascular Glucose Monitoring System
GlySure Secures CE Mark and Launches Worldās First Continuous Intravascular Glucose Monitoring System
HSMN NewsFeed - 8 Apr 2015
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
ArmaGen Announces FDA Acceptance of IND Application for AGT-181 for the Treatment of Hurler Syndrome
HSMN NewsFeed - 30 Oct 2014
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
HSMN NewsFeed - 6 Aug 2014
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
BD AutoShield(TM) Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes
HSMN NewsFeed - 23 Jul 2014
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
HSMN NewsFeed - 3 Apr 2014
Omnis Health Introduces EmbracePro(TM) ā Professional Blood Glucose Meter
Omnis Health Introduces EmbracePro(TM) ā Professional Blood Glucose Meter
HSMN NewsFeed - 13 Feb 2014
Medtronic Begins Distribution of i-port Advance(R) Injection Port Device for People with Diabetes
Medtronic Begins Distribution of i-port Advance(R) Injection Port Device for People with Diabetes
HSMN NewsFeed - 6 Feb 2014
Medtronic Introduces New Generation Enlite Sensor for People with Diabetes Across Western Europe
Medtronic Introduces New Generation Enlite Sensor for People with Diabetes Across Western Europe
HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
HSMN NewsFeed - 19 Dec 2013
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
ViaCyte Appoints Mark Foletta, former CFO of Amylin, to its Board of Directors
HSMN NewsFeed - 21 Oct 2013
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
HSMN NewsFeed - 27 Sep 2013
Medtronic Gains Approval of First Artificial Pancreas Device System with Threshold Suspend Automation
Medtronic Gains Approval of First Artificial Pancreas Device System with Threshold Suspend Automation
HSMN NewsFeed - 17 Sep 2013
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
HSMN NewsFeed - 3 Sep 2013
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
BioMarin Appoints Richard Ranieri as Senior Vice President, Human Resources and Corporate Affairs
HSMN NewsFeed - 23 Aug 2013
Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field from Abbott
Bosch Healthcare Reacquires the Rights to Its Patents in the Diabetes Field from Abbott
HSMN NewsFeed - 21 Aug 2013
Novo Nordisk receives U.S. FDA clearance for the insulin injection device NovoPen Echo(R)
Novo Nordisk receives U.S. FDA clearance for the insulin injection device NovoPen Echo(R)
HSMN NewsFeed - 27 Jun 2013
Medtronic Issues Medical Device Notifications Regarding the SynchroMed(R) Implantable Infusion System
Medtronic Issues Medical Device Notifications Regarding the SynchroMed(R) Implantable Infusion System
HSMN NewsFeed - 9 May 2013
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
HSMN NewsFeed - 15 Apr 2013
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx(R) Blood Glucose Meters in the United States
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx(R) Blood Glucose Meters in the United States
HSMN NewsFeed - 6 Mar 2013
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
GI Dynamics Announces Agreement with CMS Medical for Distribution of EndoBarrier(R) Therapy in Brazil
HSMN NewsFeed - 14 Feb 2013
Cardinal Health To Acquire AssuraMed, Leading Direct-To-Home Medical Supplies Distributor for $2.07 Billion
Cardinal Health To Acquire AssuraMed, Leading Direct-To-Home Medical Supplies Distributor for $2.07 Billion
HSMN NewsFeed - 19 Nov 2012
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
HSMN NewsFeed - 8 Oct 2012
U.S. FDA Approves the Dexcom G4(TM) PLATINUM Continuous Glucose Monitor (CGM)
U.S. FDA Approves the Dexcom G4(TM) PLATINUM Continuous Glucose Monitor (CGM)
HSMN NewsFeed - 8 Oct 2012
Hygieiaās d-Nav(TM) Receives CE Mark; First DIGS(TM) Use on U.K. Horizon
Hygieiaās d-Nav(TM) Receives CE Mark; First DIGS(TM) Use on U.K. Horizon
HSMN NewsFeed - 1 Oct 2012
Roche Diagnostics ACCU-CHEK Combo Insulin Pump System Now Available in United States
Roche Diagnostics ACCU-CHEK Combo Insulin Pump System Now Available in United States
HSMN NewsFeed - 7 Jun 2012
D. Medical Signs an Additional U.S. Distribution Agreement for Spring Universal Infusion Sets
D. Medical Signs an Additional U.S. Distribution Agreement for Spring Universal Infusion Sets
HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
HSMN NewsFeed - 22 May 2012
FDA Approves Levemir(R) for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
FDA Approves Levemir(R) for Expanded Use in Children Two to Five Years of Age with Type 1 Diabetes
HSMN NewsFeed - 6 Mar 2012
Islet Sciences Names Dr. George J. Todaro and Dr. Jerry L. Nader to Board of Directors
Islet Sciences Names Dr. George J. Todaro and Dr. Jerry L. Nader to Board of Directors
HSMN NewsFeed - 29 Feb 2012
Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
HSMN NewsFeed - 25 Jan 2012
D. Medical Signs Fifth U.S. Distribution Agreement for Spring Universal Infusion Sets
D. Medical Signs Fifth U.S. Distribution Agreement for Spring Universal Infusion Sets
HSMN NewsFeed - 18 Nov 2011
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia
EUSA Pharma Announces FDA Approval of Orphan Drug ERWINAZE(TM) for Treatment of Acute Lymphoblastic Leukemia
HSMN NewsFeed - 18 Oct 2011
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
HSMN NewsFeed - 6 Oct 2011
D. Medical Expands U.S. Distribution Network for Spring Universal Infusion Sets
D. Medical Expands U.S. Distribution Network for Spring Universal Infusion Sets
HSMN NewsFeed - 19 Sep 2011
OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System
OptiScan Biomedical Receives CE Mark for OptiScanner Automatic Bedside Glucose Monitoring System
HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
HSMN NewsFeed - 11 Apr 2011
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
HSMN NewsFeed - 8 Dec 2010
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
Catabasis Pharmaceuticals Secures $14.5 Million Second Tranche in Series A Financing
HSMN NewsFeed - 6 Dec 2010
Accomplished U.S. Diabetes Industry Veteran, Zoe H. Myers, Joins D. Medical as Chief Commercial Officer
Accomplished U.S. Diabetes Industry Veteran, Zoe H. Myers, Joins D. Medical as Chief Commercial Officer
HSMN NewsFeed - 15 Nov 2010
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
Santarus Announces Commercial Launch of Novel Type 2 Diabetes Drug CYCLOSET
HSMN NewsFeed - 19 Jul 2010
Phage Pharmaceuticals Appoints David Jackson as Vice President, Operations Planning
Phage Pharmaceuticals Appoints David Jackson as Vice President, Operations Planning
HSMN NewsFeed - 25 Jun 2010
Medtronic Begins Enrollment in ASPIRE Pivotal Study of Low Glucose Suspend Integrated System
Medtronic Begins Enrollment in ASPIRE Pivotal Study of Low Glucose Suspend Integrated System
HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
HSMN NewsFeed - 17 Mar 2010
Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management
Medtronic Receives FDA Approval for Industry's Most Advanced Integrated System for Diabetes Management
HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
HSMN NewsFeed - 3 Mar 2010
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
Novo Nordisk Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment
HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
HSMN NewsFeed - 2 Feb 2010
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
HSMN NewsFeed - 26 Jan 2010
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
Novo Nordisk's Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
HSMN NewsFeed - 25 Jan 2010
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
Calibra Receives 510(k) Clearance for the Finesse Insulin Patch-Pen, a Novel Way to Deliver Insulin
HSMN NewsFeed - 30 Dec 2009
Biodel Submits VIAject(R) New Drug Application to FDA for Treatment of Diabetes
Biodel Submits VIAject(R) New Drug Application to FDA for Treatment of Diabetes
HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
HSMN NewsFeed - 2 Nov 2009
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
Pico-Tesla Starts Pilot Study for Type 2 Diabetes with its Proprietary Magnetic (Magneceutical) Therapy
HSMN NewsFeed - 21 Oct 2009
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
Wellstat Therapeutics and sanofi-aventis Enter Agreement on Novel Therapy for Type II Diabetes
HSMN NewsFeed - 14 Sep 2009
InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
InteKrin Therapeutics Appoints Linda Slanec Higgins, PhD Chief Operating Officer
HSMN NewsFeed - 10 Jul 2009
Medtronic Voluntarily Recalls Specific Lots of ParadigmĀ® Quick-SetĀ® Infusion Sets in the United States
Medtronic Voluntarily Recalls Specific Lots of ParadigmĀ® Quick-SetĀ® Infusion Sets in the United States
HSMN NewsFeed - 20 May 2009
Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF Capital
Pathway Medical Technologies Closes $42.5M Series D Financing; Announces New Investment From WRF Capital
HSMN NewsFeed - 12 May 2009
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
Roche Announces Long-Term Commitment to Tackle Growing Epidemic of Diabetes
HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
HSMN NewsFeed - 2 Apr 2009
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
HSMN NewsFeed - 25 Mar 2009
Smiths Medical Announces Intent to Stop Selling Deltec Cozmo Insulin Pumps
Smiths Medical Announces Intent to Stop Selling Deltec Cozmo Insulin Pumps
HSMN NewsFeed - 17 Feb 2009
GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
HSMN NewsFeed - 31 Dec 2008
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
Nektar Announces Closing of Sale of Specific Pulmonary Delivery Assets to Novartis for $115 Million
HSMN NewsFeed - 16 Dec 2008
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration
HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 29 Oct 2008
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
FDA Approves Rapid-Acting Insulin Apidra(R) for Treatment of Children with Diabetes
HSMN NewsFeed - 27 Oct 2008
Medingo Appoints Pete Wehrly as President and Chief Executive Officer and Establishes US-based Operations
Medingo Appoints Pete Wehrly as President and Chief Executive Officer and Establishes US-based Operations
HSMN NewsFeed - 23 Sep 2008
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
HSMN NewsFeed - 18 Sep 2008
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
HSMN NewsFeed - 8 Sep 2008
Major Study Reinforces the Power of Medtronic Device for Better Diabetes Management
Major Study Reinforces the Power of Medtronic Device for Better Diabetes Management
HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
HSMN NewsFeed - 16 Jul 2008
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
HSMN NewsFeed - 27 Jun 2008
Nordic Capital and Avista Capital Partners Announce Intention to Combine Unomedical with Convatec
Nordic Capital and Avista Capital Partners Announce Intention to Combine Unomedical with Convatec
HSMN NewsFeed - 10 Jun 2008
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
Roche Moves Investigational Diabetes Drug, Taspoglutide, Into Phase III Clinical Trials
HSMN NewsFeed - 9 Jun 2008
Solianis' Non-Invasive Glucose Monitor Tracks Blood Glucose in Outpatient Study
Solianis' Non-Invasive Glucose Monitor Tracks Blood Glucose in Outpatient Study
HSMN NewsFeed - 2 Jun 2008
Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles
Huge Potential in Biosimilars if Generic Providers Overcome Regulatory Hurdles
HSMN NewsFeed - 31 May 2008
Amgen Presents New Data at ASCO on Four Investigational Molecules from Oncology Pipeline
Amgen Presents New Data at ASCO on Four Investigational Molecules from Oncology Pipeline
HSMN NewsFeed - 20 May 2008
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
HSMN NewsFeed - 28 Apr 2008
Medtronic Announces FDA Clearance of New OneTouch(R) UltraLink(TM) Blood Glucose Meter
Medtronic Announces FDA Clearance of New OneTouch(R) UltraLink(TM) Blood Glucose Meter
HSMN NewsFeed - 22 Apr 2008
Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System
Smiths Medical to Promote and Distribute Abbott's FreeStyle Navigator Continuous Glucose Monitoring System
HSMN NewsFeed - 16 Apr 2008
Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
HSMN NewsFeed - 24 Mar 2008
Medtronic Announces Sales Milestone of One Million Continuous Glucose Monitoring Sensors Worldwide
Medtronic Announces Sales Milestone of One Million Continuous Glucose Monitoring Sensors Worldwide
HSMN NewsFeed - 14 Mar 2008
Diamyd Medical: Diamyd Gets Authorization to Begin Phase III Study in the US
Diamyd Medical: Diamyd Gets Authorization to Begin Phase III Study in the US
HSMN NewsFeed - 13 Mar 2008
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
FDA Approves Abbott's FreeStyle Navigator(R) Continuous Glucose Monitoring System
HSMN NewsFeed - 7 Mar 2008
Alkermes Receives Notice from Eli Lilly Terminating Inhaled Insulin Program
Alkermes Receives Notice from Eli Lilly Terminating Inhaled Insulin Program
HSMN NewsFeed - 7 Mar 2008
Embrella Cardiovascular, Inc. Hires Carol Burns as Vice President of Product & Business Development
Embrella Cardiovascular, Inc. Hires Carol Burns as Vice President of Product & Business Development
HSMN NewsFeed - 20 Feb 2008
Cook Pharmica Names Fred Larimore, Ph.D., Vice President of Scientific Affairs, CSO
Cook Pharmica Names Fred Larimore, Ph.D., Vice President of Scientific Affairs, CSO
HSMN NewsFeed - 19 Feb 2008
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
Novo Nordisk Consolidates U.S. Diabetes Sales Leadership Under Single Vice President
HSMN NewsFeed - 12 Feb 2008
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
HSMN NewsFeed - 29 Jan 2008
Medtronic Announces FDA Approval of CGMS(R) iPRO(TM) Continuous Glucose Recorder
Medtronic Announces FDA Approval of CGMS(R) iPRO(TM) Continuous Glucose Recorder
HSMN NewsFeed - 21 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults With Type 2 Diabetes
HSMN NewsFeed - 19 Jan 2008
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
HSMN NewsFeed - 10 Jan 2008
Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
HSMN NewsFeed - 7 Jan 2008
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
John R. Riesenberger Joins MannKind as Corporate Vice President and Chief Commercialization Officer
HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
HSMN NewsFeed - 26 Nov 2007
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
Wyeth's TORISEL Receives European Commission Approval for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed - 20 Nov 2007
Elron Group Company, Medingo, Announces $27 Million Financing; Elron Will Invest up to $22 Million
Elron Group Company, Medingo, Announces $27 Million Financing; Elron Will Invest up to $22 Million
HSMN NewsFeed - 19 Nov 2007
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
HSMN NewsFeed - 19 Nov 2007
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
Sciele Signs Exclusive Agreement with Novo Nordisk to Market Prandin(R) and PrandiMet(R)
HSMN NewsFeed - 14 Nov 2007
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
Biodel Inc. Announces Appointment of Gerard Michel as CFO, VP of Corporate Development and Treasurer
HSMN NewsFeed - 8 Nov 2007
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
HSMN NewsFeed - 8 Nov 2007
Neurochem announces important initiatives to provide medical and health benefits to patients
Neurochem announces important initiatives to provide medical and health benefits to patients
Additional items found! 500

Members Archive contains
500 additional stories matching:
insulin
(Password required)
insulin
(Password required)